Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> WHA 2019 Top Issues: Budget, UHC, Access To Medicines, Emergencies, Environment 09/05/2019 William New This year’s World Health Assembly will provide perhaps the best measure to date of the World Health Organization director-general’s policies since taking office nearly two years ago. But it will also reflect changing times for country relationships and for the state of global health. Image Credits: Photo: WHO/Antoine Tardy, WHO/Antoine Tardy, WHO, WHO/J. D. Kannah. Continue reading -> New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> WHA 2019 Top Issues: Budget, UHC, Access To Medicines, Emergencies, Environment 09/05/2019 William New This year’s World Health Assembly will provide perhaps the best measure to date of the World Health Organization director-general’s policies since taking office nearly two years ago. But it will also reflect changing times for country relationships and for the state of global health. Image Credits: Photo: WHO/Antoine Tardy, WHO/Antoine Tardy, WHO, WHO/J. D. Kannah. Continue reading -> New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> WHA 2019 Top Issues: Budget, UHC, Access To Medicines, Emergencies, Environment 09/05/2019 William New This year’s World Health Assembly will provide perhaps the best measure to date of the World Health Organization director-general’s policies since taking office nearly two years ago. But it will also reflect changing times for country relationships and for the state of global health. Image Credits: Photo: WHO/Antoine Tardy, WHO/Antoine Tardy, WHO, WHO/J. D. Kannah. Continue reading -> New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> WHA 2019 Top Issues: Budget, UHC, Access To Medicines, Emergencies, Environment 09/05/2019 William New This year’s World Health Assembly will provide perhaps the best measure to date of the World Health Organization director-general’s policies since taking office nearly two years ago. But it will also reflect changing times for country relationships and for the state of global health. Image Credits: Photo: WHO/Antoine Tardy, WHO/Antoine Tardy, WHO, WHO/J. D. Kannah. Continue reading -> New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> WHA 2019 Top Issues: Budget, UHC, Access To Medicines, Emergencies, Environment 09/05/2019 William New This year’s World Health Assembly will provide perhaps the best measure to date of the World Health Organization director-general’s policies since taking office nearly two years ago. But it will also reflect changing times for country relationships and for the state of global health. Image Credits: Photo: WHO/Antoine Tardy, WHO/Antoine Tardy, WHO, WHO/J. D. Kannah. Continue reading -> New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> WHA 2019 Top Issues: Budget, UHC, Access To Medicines, Emergencies, Environment 09/05/2019 William New This year’s World Health Assembly will provide perhaps the best measure to date of the World Health Organization director-general’s policies since taking office nearly two years ago. But it will also reflect changing times for country relationships and for the state of global health. Image Credits: Photo: WHO/Antoine Tardy, WHO/Antoine Tardy, WHO, WHO/J. D. Kannah. Continue reading -> New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> WHA 2019 Top Issues: Budget, UHC, Access To Medicines, Emergencies, Environment 09/05/2019 William New This year’s World Health Assembly will provide perhaps the best measure to date of the World Health Organization director-general’s policies since taking office nearly two years ago. But it will also reflect changing times for country relationships and for the state of global health. Image Credits: Photo: WHO/Antoine Tardy, WHO/Antoine Tardy, WHO, WHO/J. D. Kannah. Continue reading -> New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> WHA 2019 Top Issues: Budget, UHC, Access To Medicines, Emergencies, Environment 09/05/2019 William New This year’s World Health Assembly will provide perhaps the best measure to date of the World Health Organization director-general’s policies since taking office nearly two years ago. But it will also reflect changing times for country relationships and for the state of global health. Image Credits: Photo: WHO/Antoine Tardy, WHO/Antoine Tardy, WHO, WHO/J. D. Kannah. Continue reading -> New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHA 2019 Top Issues: Budget, UHC, Access To Medicines, Emergencies, Environment 09/05/2019 William New This year’s World Health Assembly will provide perhaps the best measure to date of the World Health Organization director-general’s policies since taking office nearly two years ago. But it will also reflect changing times for country relationships and for the state of global health. Image Credits: Photo: WHO/Antoine Tardy, WHO/Antoine Tardy, WHO, WHO/J. D. Kannah. Continue reading -> New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> Posts navigation Older postsNewer posts